Andrea Dale Maderal

Andrea Maderal practices at UMiami Medicine - Dermatology in Miami, Florida.

Andrea Maderal's NPI, 1326380924, was assigned on March 21, 2013. Andrea Maderal graduated from University of Miami, Miller School of Medicine in 2013. Andrea Maderal holds Florida license ME131919.

Andrea Maderal's primary practice is UMiami Medicine - Dermatology, at 1444 NW 9th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Andrea Maderal's primary practice is UMiami Medicine - Dermatology in Miami, Florida. Andrea Maderal is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Andrea Maderal to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Andrea Maderal practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Andrea Maderal's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Andrea Maderal is board certified in dermatology by the American Board of Dermatology. Andrea Maderal is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Andrea Maderal treats.

CMS data shows 1,734 Medicare services from Andrea Maderal across 16 procedure codes in 2024, for 365 Medicare patients. Medicare paid $86,014 for them. Every service was in an office.

CMS counts 365 Medicare patients who saw Andrea Maderal in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Andrea Maderal's median patient age at 54, with 63% women.

In 2024, Andrea Maderal wrote 1,220 Medicare Part D claims for 258 patients. 89% of them were for generic drugs. CMS names the drug for 1,035 of them, across 32 drugs with 11 or more claims each, at $519,547 in total drug cost. In 2023, CMS named 904 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Andrea Maderal for performance year 2024, reported as part of a group. Andrea Maderal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Andrea Maderal as offering telehealth. CMS counts 450 procedures of removal of skin lesions by Andrea Maderal, more than 85% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 52 papers to Andrea Maderal, published from 2011 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Dermatomyositis, Lupus Erythematosus, Systemic and Skin. Andrea Maderal has published most often in Int J Dermatol. Andrea Maderal's most frequent co-authors are Robert S. Kirsner, MD, Alejandra Carolina Vivas, MD and Scott A. Elman, MD.

CMS Open Payments shows 43 general payments to Andrea Maderal from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 86% of the total. Argenx US, Inc. paid the most, $15,190.

Andrea Maderal graduated from University of Miami, Miller School of Medicine in 2013.

Andrea Maderal is in network with 12 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.